Mandate

Stora Enso increases its holding in Cellutech

October 29, 2018 M&A

Vinge has advised Cellutech in connection with the minority shareholder Stora Enso acquiring all shares in the company.

Cellutech was founded in 2013 and consists of an active team with eight scientists and researchers who act as a link between academia and industry.

Cellutech was started in order to develop ideas from high class technology research at SweTree Technologies and Wallenberg Wood Science Center to commercially successful technology and products.

Vinge’s team consisted of Johan Winnerblad and Kristina Ekberg.
 

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025